Vistagen Therapeutics
Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

$71M

Market Cap • 12/25/2024

1998

(26 years)
Founded

2009

(15 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

South San Francisco

Headquarters • California